Eurasian patent in the field of anti-cancer technology No. 42000

25 january 2023

Interesting

The Eurasian Patent Office registered invention No. 42000, owned by the American company Regeneron Pharmaceuticals Inc. The patent discloses new antibody variants that can be used to treat a wide range of cancers: blood cancer, brain cancer, kidney cancer, etc.

Regeneron Pharmaceuticals Inc. - is an active user of the Eurasian patent system. The company holds 56 Eurasian patents for inventions, with a total of 222 patent applications filed on behalf of Regeneron Pharmaceuticals Inc.

Source - EAPO

More IP news – in our social networks (Facebook, Instagram, Telegram).